Fiebre maculosa de las Montañas Rocosas en niños y adolescentes mexicanos: Cuadro clínico y factores de mortalidad

Translated title of the contribution: Rocky Mountain spotted fever in Mexican children: Clinical and mortality factors

Gerardo Álvarez-Hernández*, María del Carmen Candia-Plata, Jesús Delgado-de la Mora, Natalia Haydeé Acuña-Meléndrez, Anabel Patricia Vargas-Ortega, Jesús David Licona-Enríquez

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Objective: Characterize clinical manifestations and predictors of mortality in children hospitalized for spotted fever. Materials and methods: Cross-sectional study in 210 subjects with a diagnosis of Rocky Mountain spotted fever (RMSF) in a pediatric hospital in Sonora, from January 1st, 2004 to June 30th, 2015. Data were analyzed using descriptive statistics and multivariate logistic regression. Results: An upward trend was observed in RMSF morbidity and mortality. Fatality rate was 30%. Three predictors were associated with risk of death: delay ≥ 5 days at the start of doxycycline (ORa = 2.95, 95% CI 1.10-7.95), acute renal failure ((ORa = 8.79, 95% CI 3.46-22.33) and severe sepsis (ORa = 3.71, 95% CI 1.44-9.58). Conclusions: RMSF causes high mortality in children, which can be avoided with timely initiation of doxycycline. Acute renal failure and severe sepsis are two independent predictors of death in children with RMSF.

Translated title of the contributionRocky Mountain spotted fever in Mexican children: Clinical and mortality factors
Original languageSpanish
Pages (from-to)385-392
Number of pages8
JournalSalud publica de Mexico
Volume58
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Dive into the research topics of 'Rocky Mountain spotted fever in Mexican children: Clinical and mortality factors'. Together they form a unique fingerprint.

Cite this